Breaking News Instant updates and real-time market news.

RGNX

Regenxbio

$34.79 /

-2.27 (-6.13%)

07:09
12/01/20
12/01
07:09
12/01/20
07:09

Regenxbio doses first patient in Phase I/II trial of RGX-111

REGENXBIO announced that the first patient has been dosed in the Phase I/II trial of RGX-111 for the treatment of Mucopolysaccharidosis Type I, or MPS I. RGX-111 is an investigational one-time gene therapy designed to deliver the alpha-l-iduronidase, or IDUA, gene directly to the central nervous system, or CNS, using the NAV AAV9 vector. MPS I is a rare, autosomal recessive genetic disease caused by deficiency of IDUA, an enzyme required for the breakdown of the polysaccharides in lysosomes. These polysaccharides, called glycosaminoglycans, GAGs, accumulate in tissues of MPS I patients, resulting in characteristic storage lesions and diverse clinical signs and symptoms including in the central nervous system, or CNS,, which can include excessive accumulation of fluid in the brain, spinal cord compression, and cognitive impairment.

RGNX Regenxbio
$34.79 /

-2.27 (-6.13%)

11/25/20 H.C. Wainwright
Abeona Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Brunswick expands access to on-water training, launches BoatClass » 07:16
01/19/21
01/19
07:16
01/19/21
07:16
BC

Brunswick

$87.97 /

-1.09 (-1.22%)

Brunswick Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$87.97 /

-1.09 (-1.22%)

BC Brunswick
$87.97 /

-1.09 (-1.22%)

01/12/21 B. Riley Securities
Brunswick price target raised to $102 from $93 at B. Riley Securities
11/20/20 JPMorgan
Brunswick price target raised to $85 from $79 at JPMorgan
10/20/20 JPMorgan
Brunswick upgraded to Overweight on surging boat sales at JPMorgan
10/20/20 JPMorgan
Brunswick upgraded to Overweight from Neutral at JPMorgan
BC Brunswick
$87.97 /

-1.09 (-1.22%)

Recommendations
Capital One price target raised to $130 from $105 at Oppenheimer » 07:16
01/19/21
01/19
07:16
01/19/21
07:16
COF

Capital One

$112.57 /

-1.835 (-1.60%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COF Capital One
$112.57 /

-1.835 (-1.60%)

COF Capital One
$112.57 /

-1.835 (-1.60%)

01/06/21 Deutsche Bank
Capital One upgraded to Buy with 23% upside potential at Deutsche Bank
01/05/21 Deutsche Bank
Capital One upgraded to Buy from Hold at Deutsche Bank
01/04/21 Wells Fargo
Capital One price target raised to $120 from $100 at Wells Fargo
01/04/21 Barclays
Capital One price target raised to $133 from $91 at Barclays
COF Capital One
$112.57 /

-1.835 (-1.60%)

COF Capital One
$112.57 /

-1.835 (-1.60%)

COF Capital One
$112.57 /

-1.835 (-1.60%)

COF Capital One
$112.57 /

-1.835 (-1.60%)

Hot Stocks
Heritage Cannabis subsidiary enters supply agreement with Entourage Phytolab » 07:15
01/19/21
01/19
07:15
01/19/21
07:15
HERTF

Heritage Cannabis

$0.00 /

+ (+0.00%)

Heritage Cannabis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HERTF Heritage Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Verizon, Unity partner for 5G, Mobile Edge Compute applications » 07:15
01/19/21
01/19
07:15
01/19/21
07:15
VZ

Verizon

$57.39 /

+0.35 (+0.61%)

, U

Unity Software

$148.45 /

-1.54 (-1.03%)

Verizon (VZ) and Unity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
$57.39 /

+0.35 (+0.61%)

U Unity Software
$148.45 /

-1.54 (-1.03%)

VZ Verizon
$57.39 /

+0.35 (+0.61%)

12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
11/16/20 Wells Fargo
Verizon resumed with an Equal Weight at Wells Fargo
U Unity Software
$148.45 /

-1.54 (-1.03%)

01/15/21 Credit Suisse
Unity Software assumed with an Outperform at Credit Suisse
01/11/21 Piper Sandler
Unity Software price target raised to $150 from $115 at Piper Sandler
11/30/20 Oppenheimer
Unity Software downgraded to Perform at Oppenheimer
11/30/20 Oppenheimer
Unity Software downgraded to Perform from Outperform at Oppenheimer
VZ Verizon
$57.39 /

+0.35 (+0.61%)

U Unity Software
$148.45 /

-1.54 (-1.03%)

  • 18
    Sep
VZ Verizon
$57.39 /

+0.35 (+0.61%)

U Unity Software
$148.45 /

-1.54 (-1.03%)

VZ Verizon
$57.39 /

+0.35 (+0.61%)

U Unity Software
$148.45 /

-1.54 (-1.03%)

VZ Verizon
$57.39 /

+0.35 (+0.61%)

U Unity Software
$148.45 /

-1.54 (-1.03%)

Hot Stocks
Velodyne Lidar Trunk.Tech Announce strategic partnership for autonomous trucking » 07:14
01/19/21
01/19
07:14
01/19/21
07:14
VLDR

Velodyne Lidar

$22.95 /

-1.16 (-4.81%)

Velodyne Lidar announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 Benchmark
Benchmark starts 'first mover' Velodyne Lidar at Buy with $32 price target
01/14/21 Benchmark
Velodyne Lidar initiated with a Buy at Benchmark
01/08/21 Craig-Hallum
Craig-Hallum a buyer of Velodyne after 'frustrating' preannouncement
VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

VLDR Velodyne Lidar
$22.95 /

-1.16 (-4.81%)

Upgrade
Evercore ISI upgrades 'COVID recovery idea' WWE to Outperform » 07:14
01/19/21
01/19
07:14
01/19/21
07:14
WWE

WWE

$50.86 /

-0.89 (-1.72%)

Evercore ISI analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WWE WWE
$50.86 /

-0.89 (-1.72%)

WWE WWE
$50.86 /

-0.89 (-1.72%)

06:21 Today Evercore ISI
WWE upgraded to Outperform from In Line at Evercore ISI
01/11/21
Fly Intel: Top five analyst initiations
01/11/21 Barclays
WWE initiated with an Equal Weight at Barclays
10/27/20 Morgan Stanley
WWE price target lowered to $47 from $52 at Morgan Stanley
WWE WWE
$50.86 /

-0.89 (-1.72%)

  • 25
    Mar
WWE WWE
$50.86 /

-0.89 (-1.72%)

WWE WWE
$50.86 /

-0.89 (-1.72%)

Hot Stocks
Iceland Foods extends distribution partnership with XPO Logistics » 07:13
01/19/21
01/19
07:13
01/19/21
07:13
XPO

XPO Logistics

$118.85 /

-1.915 (-1.59%)

XPO Logistics has renewed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

06:09 Today UBS
XPO Logistics initiated with a Buy at UBS
01/12/21 JPMorgan
XPO Logistics price target raised to $135 from $122 at JPMorgan
01/08/21 Barclays
XPO Logistics price target raised to $136 from $100 at Barclays
12/07/20 Credit Suisse
XPO Logistics price target raised to $140 from $114 at Credit Suisse
XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

XPO XPO Logistics
$118.85 /

-1.915 (-1.59%)

Hot Stocks
Seres Therapeutics to present new SER-109 data at Keystone Symposium » 07:13
01/19/21
01/19
07:13
01/19/21
07:13
MCRB

Seres Therapeutics

$24.47 /

-2.26 (-8.45%)

Seres Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$24.47 /

-2.26 (-8.45%)

MCRB Seres Therapeutics
$24.47 /

-2.26 (-8.45%)

01/12/21 Piper Sandler
Additional Seres '109 analysis strengthens BLA filing, says Piper Sandler
12/23/20 JMP Securities
Seres Therapeutics initiated with a Market Perform at JMP Securities
11/09/20 Oppenheimer
Seres Therapeutics price target raised to $38 from $34 at Oppenheimer
11/09/20 Piper Sandler
Seres Therapeutics price target raised to $49 from $40 at Piper Sandler
MCRB Seres Therapeutics
$24.47 /

-2.26 (-8.45%)

  • 13
    Aug
MCRB Seres Therapeutics
$24.47 /

-2.26 (-8.45%)

MCRB Seres Therapeutics
$24.47 /

-2.26 (-8.45%)

Hot Stocks
CytoSorb approved in Korea for all EU approved indications » 07:13
01/19/21
01/19
07:13
01/19/21
07:13
CTSO

CytoSorbents

$8.58 /

-0.21 (-2.39%)

, FMS

Fresenius Medical

$41.61 /

-0.14 (-0.34%)

CytoSorbents (CTSO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSO CytoSorbents
$8.58 /

-0.21 (-2.39%)

CTSO CytoSorbents
$8.58 /

-0.21 (-2.39%)

01/04/21 B. Riley Securities
CytoSorbents price target raised to $17 from $16 at B. Riley Securities
09/01/20 SVB Leerink
CytoSorbents initiated with an Outperform at SVB Leerink
08/25/20 B. Riley FBR
CytoSorbents 29% pullback from highs a buying opportunity, says B. Riley FBR
06/02/20 B. Riley FBR
CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR
FMS Fresenius Medical
$41.61 /

-0.14 (-0.34%)

01/11/21 Jefferies
Fresenius Medical downgraded to Underperform from Hold at Jefferies
12/09/20 Morgan Stanley
Fresenius Medical price target raised to EUR 75 from EUR 74 at Morgan Stanley
11/10/20 Deutsche Bank
Fresenius Medical price target lowered to EUR 87 from EUR 97 at Deutsche Bank
11/05/20 UBS
Fresenius Medical price target lowered to EUR 94 from EUR 95 at UBS
CTSO CytoSorbents
$8.58 /

-0.21 (-2.39%)

  • 22
    Jul
FMS Fresenius Medical
$41.61 /

-0.14 (-0.34%)

Hot Stocks
Miragen Therapeutics appoints Jonathan Violin as CEO, Barrett Katz as CMO » 07:12
01/19/21
01/19
07:12
01/19/21
07:12
MGEN

Miragen Therapeutics

$23.29 /

-1.8 (-7.17%)

, VRDN

Viridian Therapeutics

$0.00 /

+ (+0.00%)

, BBIO

BridgeBio

$68.61 /

-1.19 (-1.70%)

The Company announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

VRDN Viridian Therapeutics
$0.00 /

+ (+0.00%)

BBIO BridgeBio
$68.61 /

-1.19 (-1.70%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

12/31/20 Oppenheimer
Miragen Therapeutics price target raised to $37 from $5 at Oppenheimer
12/15/20 JMP Securities
Miragen Therapeutics initiated with an Outperform at JMP Securities
11/24/20 Wedbush
Miragen Therapeutics assumed with Outperform rating at Wedbush
10/06/20
Fly Intel: Top five analyst downgrades
VRDN Viridian Therapeutics
$0.00 /

+ (+0.00%)

BBIO BridgeBio
$68.61 /

-1.19 (-1.70%)

01/11/21 H.C. Wainwright
BridgeBio price target raised to $87 from $64 at H.C. Wainwright
12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
12/14/20 BTIG
BridgeBio price target raised to $91 from $49 at BTIG
12/10/20 H.C. Wainwright
BridgeBio price target raised to $64 from $53 at H.C. Wainwright
MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

BBIO BridgeBio
$68.61 /

-1.19 (-1.70%)

  • 29
    May
BBIO BridgeBio
$68.61 /

-1.19 (-1.70%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

Hot Stocks
Taysha gets both rare pediatric disease and orphan drug designations for TSHA-10 » 07:12
01/19/21
01/19
07:12
01/19/21
07:12
TSHA

Taysha Gene Therapies

$29.86 /

+1.21 (+4.22%)

Taysha Gene Therapies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$29.86 /

+1.21 (+4.22%)

TSHA Taysha Gene Therapies
$29.86 /

+1.21 (+4.22%)

01/04/21 Oppenheimer
Taysha Gene Therapies initiated with an Outperform at Oppenheimer
10/19/20 Chardan
Taysha Gene Therapies initiated with a Buy at Chardan
10/19/20 Jefferies
Taysha Gene Therapies initiated with a Buy at Jefferies
10/19/20 Morgan Stanley
Taysha Gene Therapies initiated with an Overweight at Morgan Stanley
  • 24
    Sep
Initiation
Xpeng initiated with a Hold at Jefferies » 07:11
01/19/21
01/19
07:11
01/19/21
07:11
XPEV

Xpeng

$47.83 /

-2.51 (-4.99%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

01/04/21 Citi
Xpeng partnership with Livox is 'very positive,' says Citi
12/21/20 Wedbush
Tesla price target raised to $715 from $560 at Wedbush
12/14/20
Fly Intel: Top five analyst initiations
12/14/20 Daiwa
Xpeng initiated with a Sell at Daiwa
XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

  • 09
    Dec
  • 27
    Aug
XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

XPEV Xpeng
$47.83 /

-2.51 (-4.99%)

Hot Stocks
Applied DNA Sciences announces Linea COVID-19 Assay Kit identifies variants » 07:11
01/19/21
01/19
07:11
01/19/21
07:11
APDN

Applied DNA Sciences

$10.94 /

+2.06 (+23.20%)

Applied DNA Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APDN Applied DNA Sciences
$10.94 /

+2.06 (+23.20%)

APDN Applied DNA Sciences
$10.94 /

+2.06 (+23.20%)

01/14/21 H.C. Wainwright
Applied DNA Sciences price target lowered to $14 from $18 at H.C. Wainwright
01/11/21 H.C. Wainwright
Applied DNA Sciences price target raised to $18 from $12 at H.C. Wainwright
12/30/20 H.C. Wainwright
H.C. Wainwright keeps $12 target on Applied DNA Sciences after partnership
12/18/20 H.C. Wainwright
Applied DNA Sciences price target lowered to $12 from $20 at H.C. Wainwright
APDN Applied DNA Sciences
$10.94 /

+2.06 (+23.20%)

Hot Stocks
Miragen Therapeutics changes name to Viridian Therapeutics » 07:10
01/19/21
01/19
07:10
01/19/21
07:10
MGEN

Miragen Therapeutics

$23.29 /

-1.8 (-7.17%)

, VRDN

Viridian Therapeutics

$0.00 /

+ (+0.00%)

miRagen Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

12/31/20 Oppenheimer
Miragen Therapeutics price target raised to $37 from $5 at Oppenheimer
12/15/20 JMP Securities
Miragen Therapeutics initiated with an Outperform at JMP Securities
11/24/20 Wedbush
Miragen Therapeutics assumed with Outperform rating at Wedbush
10/06/20
Fly Intel: Top five analyst downgrades
VRDN Viridian Therapeutics
$0.00 /

+ (+0.00%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

Hot Stocks
Nevro announces data supporting use of HF10 therapy » 07:09
01/19/21
01/19
07:09
01/19/21
07:09
NVRO

Nevro

$175.11 /

-0.555 (-0.32%)

Nevro announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

NVRO Nevro
$175.11 /

-0.555 (-0.32%)

01/06/21 Truist
Nevro price target raised to $205 from $175 at Truist
01/05/21 Baird
Nevro price target raised to $200 from $180 at Baird
01/04/21 Wells Fargo
Nevro price target raised to $215 from $177 at Wells Fargo
12/31/20 Guggenheim
Nevro price target raised to $205 from $190 at Guggenheim
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

  • 02
    Apr
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

Recommendations
Peck price target raised to $22 from $9.50 at Alliance Global Partners » 07:09
01/19/21
01/19
07:09
01/19/21
07:09
PECK

Peck

$16.13 /

-2.7 (-14.34%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PECK Peck
$16.13 /

-2.7 (-14.34%)

PECK Peck
$16.13 /

-2.7 (-14.34%)

12/21/20 Alliance Global Partners
Peck initiated with a Buy at Alliance Global Partners
Recommendations
Cloudflare price target raised to $85 from $70 at RBC Capital » 07:09
01/19/21
01/19
07:09
01/19/21
07:09
NET

Cloudflare

$77.86 /

-2.595 (-3.23%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$77.86 /

-2.595 (-3.23%)

NET Cloudflare
$77.86 /

-2.595 (-3.23%)

12/15/20 BTIG
BTIG raises price targets on select security and software applications names
12/09/20 JPMorgan
Cloudflare downgraded to Neutral from Overweight at JPMorgan
12/01/20
Fly Intel: Top five analyst initiations
12/01/20 KeyBanc
Cloudflare initiated with an Overweight at KeyBanc
NET Cloudflare
$77.86 /

-2.595 (-3.23%)

NET Cloudflare
$77.86 /

-2.595 (-3.23%)

NET Cloudflare
$77.86 /

-2.595 (-3.23%)

NET Cloudflare
$77.86 /

-2.595 (-3.23%)

Hot Stocks
LabCorp appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer » 07:08
01/19/21
01/19
07:08
01/19/21
07:08
LH

LabCorp

$223.54 /

+3.38 (+1.54%)

Labcorp announced today…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$223.54 /

+3.38 (+1.54%)

LH LabCorp
$223.54 /

+3.38 (+1.54%)

01/14/21 Mizuho
LabCorp price target raised to $242 from $234 at Mizuho
01/11/21
Fly Intel: Top five analyst upgrades
01/11/21 Argus
LabCorp upgraded to Buy from Hold at Argus
01/11/21 Argus
LabCorp upgraded to Buy from Hold at Argus
LH LabCorp
$223.54 /

+3.38 (+1.54%)

LH LabCorp
$223.54 /

+3.38 (+1.54%)

LH LabCorp
$223.54 /

+3.38 (+1.54%)

LH LabCorp
$223.54 /

+3.38 (+1.54%)

Initiation
United Bancorp Alabama initiated with a Buy at Janney Montgomery Scott » 07:08
01/19/21
01/19
07:08
01/19/21
07:08
UBAB

United Bancorp Alabama

$0.00 /

+ (+0.00%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Scopus BioPharma completes clinical lot manufacturing » 07:08
01/19/21
01/19
07:08
01/19/21
07:08
SCPS

Scopus BioPharma

$13.30 /

+0.29 (+2.23%)

Scopus BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 16
    Dec
Downgrade
H2O Innovation downgraded to Hold from Buy at Canaccord » 07:08
01/19/21
01/19
07:08
01/19/21
07:08
HEOFF

H2O Innovation

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

12/11/20 Canaccord
H2O Innovation price target raised to C$2.60 from C$2.50 at Canaccord
12/07/20 Canaccord
H2O Innovation resumed with a Buy at Canaccord
09/25/20 Industrial Alliance
H2O Innovation upgraded to Buy from Speculative Buy at Industrial Alliance
09/21/20 Desjardins
H2O Innovation initiated with a Buy at Desjardins
HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

Hot Stocks
Aclaris Therapeutics announces topline data from Phase 2a trial of ATI-450 » 07:07
01/19/21
01/19
07:07
01/19/21
07:07
ACRS

Aclaris Therapeutics

$5.88 /

-0.2 (-3.29%)

Aclaris Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$5.88 /

-0.2 (-3.29%)

ACRS Aclaris Therapeutics
$5.88 /

-0.2 (-3.29%)

Hot Stocks
Avrobio appoints Diana Escolar as CMO » 07:07
01/19/21
01/19
07:07
01/19/21
07:07
AVRO

Avrobio

$14.39 /

-0.52 (-3.49%)

, MGEN

Miragen Therapeutics

$23.29 /

-1.8 (-7.17%)

Avrobio (AVRO) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVRO Avrobio
$14.39 /

-0.52 (-3.49%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

AVRO Avrobio
$14.39 /

-0.52 (-3.49%)

11/18/20 Mizuho
Avrobio price target raised to $43 from $35 at Mizuho
11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Avrobio initiated with a Buy at Berenberg
03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

12/31/20 Oppenheimer
Miragen Therapeutics price target raised to $37 from $5 at Oppenheimer
12/15/20 JMP Securities
Miragen Therapeutics initiated with an Outperform at JMP Securities
11/24/20 Wedbush
Miragen Therapeutics assumed with Outperform rating at Wedbush
10/06/20
Fly Intel: Top five analyst downgrades
AVRO Avrobio
$14.39 /

-0.52 (-3.49%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

  • 20
    Nov
  • 13
    Feb
AVRO Avrobio
$14.39 /

-0.52 (-3.49%)

MGEN Miragen Therapeutics
$23.29 /

-1.8 (-7.17%)

Hot Stocks
Bausch + Lomb completes enrollment of first Phase 3 Study for NOV03 » 07:07
01/19/21
01/19
07:07
01/19/21
07:07
BHC

Bausch Health

$26.40 /

-0.01 (-0.04%)

Bausch + Lomb, a health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$26.40 /

-0.01 (-0.04%)

BHC Bausch Health
$26.40 /

-0.01 (-0.04%)

01/15/21 Jefferies
Bausch Health price target raised to $33 from $27 at Jefferies
01/13/21 Truist
Bausch Health CEO discussed inbound interest at conference, says Truist
11/05/20 Piper Sandler
Bausch Health price target lowered to $25 from $26 at Piper Sandler
10/26/20 Barclays
Bausch Health price target raised to $29 from $28 at Barclays
BHC Bausch Health
$26.40 /

-0.01 (-0.04%)

BHC Bausch Health
$26.40 /

-0.01 (-0.04%)

BHC Bausch Health
$26.40 /

-0.01 (-0.04%)

Initiation
First Reliance initiated with a Buy at Janney Montgomery Scott » 07:07
01/19/21
01/19
07:07
01/19/21
07:07
FSRL

First Reliance

$0.00 /

+ (+0.00%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.